Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)

SEK 1.48

(0.68%)

Market Cap (In SEK)

34.31 Million

Revenue (In SEK)

2.82 Million

Net Income (In SEK)

-21.09 Million

Avg. Volume

14.51 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.3-5.2
PE
-
EPS
-
Beta Value
1.32
ISIN
SE0009242654
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Stefan Mohan Frick
Employee Count
-
Website
https://chemotech.se
Ipo Date
2016-12-06
Details
Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.